Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Illumina Taking a Stab at Early-Stage Cancer Detection Test

January 11, 2016 1:06 pm | by Greg Watry, Digital Reporter | News | Comments

Over the weekend, the San Diego-based Illumina announced that its blood tests should reach the market by 2019, and cost around $1,000 or less. Read more...


New Coalition Forms to Fight Cancer

January 11, 2016 12:15 pm | by Ryan Bushey, Associate Editor | News | Comments

All participants will work together to enroll 20,000 patients in a large swath of clinical trials by the year 2020. Read more...


Shire, Baxalta Agree to $31 Billion Merger

January 11, 2016 10:55 am | by Ryan Bushey, Associate Editor | News | Comments

Both companies currently have 60 drugs in development.


AbbVie: Phase 3 Clinical Trial Launch Evaluating Selective JAK1 Inhibitor, for RA Treatment

January 11, 2016 10:38 am | News | Comments

AbbVie, a global biopharmaceutical company, today announced the start of a large Phase 3 clinical trial program to study the use of ABT-494, an investigational, once-daily, oral selective JAK1 inhibitor for the treatment of rheumatoid arthritis (RA). Read more...


New Mechanism

January 11, 2016 10:29 am | by Harvard University | News | Comments

A new study from researchers at Harvard Medical School and Massachusetts Eye and Ear showed that in some cases of vestibular schwannoma, a potentially lethal tumor often associated with neurofibromatosis 2 (NF2), secretions from the tumor contain toxic molecules that damage the inner ear. Read more...


Pfizer Raises Prices for 105 Drugs on New Year's Day

January 11, 2016 9:55 am | by Ryan Bushey, Associate Editor | News | Comments

No price reductions were reported. This news comes on the heels of Pfizer’s planned merger with Dublin, Ireland-based Allergan. Read more...


Chinese Woman Dies of H5N6 Bird Flu, Another Woman Critical

January 11, 2016 8:15 am | by The Associated Press | News | Comments

 Health authorities in southern China said Tuesday that a 26-year-old woman has died of a strain of bird flu, and another woman is reportedly in serious condition. Read more...


BRCA1 Deficiency Increases Sensitivity of Ovarian Cancer Cells to Auranofin

January 11, 2016 8:00 am | by Plymouth University | News | Comments

Auranofin is currently undergoing trials for repurposing to treat recurrent epithelial ovarian cancer, which makes up around 90 per cent of diagnosed ovarian cancers. Read more...


Ebola Medical Team Develops Guidelines for Treating Infected Children

January 11, 2016 7:45 am | by Washington University in St. Louis | News | Comments

When the Ebola virus outbreak erupted in West Africa in 2014, children infected with the virus -- particularly those under age 5 -- faced overwhelming challenges. Read more...


Mylan Launches Generic Ortho Tri-Cyclen Lo Tablets

January 11, 2016 7:30 am | News | Comments

The product is indicated for the prevention of pregnancy. Read more...


In Defense of Pathogenic Proteins

January 11, 2016 7:15 am | by ETH Zurich | News | Comments

We age because the cells in our bodies begin to malfunction over the years. Read more...


J&J, Janssen Announce New Collaboration for Developing HBV Treatments

January 11, 2016 7:00 am | News | Comments

The agreement will address the significant unmet medical need inflicted by HBV. Read more...


Dherbs Hit With Warning Letter for Selling Unapproved Supplements

January 8, 2016 12:03 pm | by FDAnews | News | Comments

A Los Angeles area supplement provider has been hit with an FDA warning letter for selling unapproved drugs for conditions ranging from kidney stones to stroke prevention. Read more..


Drug Discovery Spotlight: Cancer Struggle Hit Home for FDA Regulator; Optogenetics Possibilities

January 8, 2016 11:55 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we’ve rounded up this week’s trending headlines. Read more...


Drug Developers Are Working to Boost R&D Productivity, But Need to Do More to Achieve Large-Scale Improvements

January 8, 2016 9:56 am | by Tufts Center for the Study of Drug Development | News | Comments

While drug developers during the coming year will continue their efforts to meet the growing demand for innovative new medicines, they must also significantly scale up their level of process improvements if they are to reduce the time and cost required to bring new drugs to market, according to the Tufts Center for the Study of Drug Development. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.